By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Matinas BioPharma 

915 Klosterman Road East

Tarpon Springs  Florida  34689  U.S.A.
Phone: 1-908-443-1860 Fax: n/a


Company News
Matinas BioPharma Completes Private Placement of $8 Million 9/13/2016 8:29:33 AM
Matinas BioPharma's Lead Antifungal Product Candidate MAT2203 Granted QIDP And Fast Track Designations For Prophylaxis Of Invasive Fungal Infections By U.S. FDA 9/7/2016 9:16:52 AM
Matinas BioPharma Announces Presentation Of Cryptococcal Meningitis Preclinical Data Of MAT2203 At AIDS-Associated Mycosis Meeting 2016 7/13/2016 8:19:35 AM
Matinas BioPharma Receives Notice Of Allowance Of U.S. Patent For Novel Lipid-Crystal Nano-Particle Cochleate Formulation Technology 2/10/2016 8:14:30 AM
Matinas BioPharma Commences Patient Enrollment In NIH-Sponsored Phase IIa Study With MAT2203 - Oral Encochleated Amphotericin B 2/8/2016 6:59:36 AM
Matinas BioPharma To Present At The 8th Annual LD Micro Main Event On December 3, 2015 11/19/2015 11:21:44 AM
Matinas BioPharma Reports 2015 Third Quarter Financial Results And Provides Business Update 11/10/2015 8:18:58 AM
Matinas BioPharma Receives Notice Of Allowance Of U.S. Patent For Encochleated siRNA 10/26/2015 12:25:23 PM
Matinas BioPharma Selected To Present At Cavendish Global Health Impact Forum 10/22/2015 8:23:27 AM
Matinas BioPharma Presents Pre-Clinical Data Showing Anti-Bacterial Activity Of MAT2501 - Encochleated Amikacin - Against Mycobacterium Avium Lung Infections At ICAAC/ICC 2015 9/21/2015 8:04:01 AM